Projects funded by the NCN
Antidepressats as substances that increase the activity of risperidone, an atypical antipsychotic drug in animal models
2013/09/N/NZ7/02143
Keywords:
schizophrenia risperidone mirtazapine escitaloprame
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii PAN
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 5 - announced on 2013-03-15
Amount awarded: 149 500 PLN
Project start date (Y-m-d): 2014-02-24
Project end date (Y-m-d): 2017-02-23
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled